Cita APA

Hamid, M., Heilbrun, L. K., Maier, J., Devisetty, K., Connolly, I., Kaufman, I., . . . Heath, E. I. (2021). A Phase 1 study Combining Pexidartinib, Radiation Therapy, and Androgen Deprivation Therapy in Men With Intermediate- and High-Risk Prostate Cancer. Adv Radiat Oncol.

Citación estilo Chicago

Hamid, Muhammad, et al. "A Phase 1 Study Combining Pexidartinib, Radiation Therapy, and Androgen Deprivation Therapy in Men With Intermediate- and High-Risk Prostate Cancer." Adv Radiat Oncol 2021.

Cita MLA

Hamid, Muhammad, et al. "A Phase 1 Study Combining Pexidartinib, Radiation Therapy, and Androgen Deprivation Therapy in Men With Intermediate- and High-Risk Prostate Cancer." Adv Radiat Oncol 2021.